From Wikipedia Retrophin filed a $65 million

From Wikipedia

Retrophin filed a $65 million lawsuit against Shkreli in August 2015,[7] claiming he breached his duty of loyalty to the biopharmaceutical company in a long-running dispute over his use of company funds,[9][10] and alleging that he "committed stock-trading irregularities and other violations of securities rules".[11] The lawsuit includes the claim that Shkreli threatened and harassed a former MSMB employee and his family.[11] Shkreli and some of his business associates have been under criminal investigation by the U.S. Attorney for the Eastern District of New York since January 2015 with respect to their Retrophin activities, and Shkreli has invoked his Fifth Amendment right against self-incrimination in order to avoid testifying during civil depositions.[12][

In 2011, Shkreli filed requests with the U.S. Food and Drug Administration (FDA) to reject a new type of cancer diagnostic from the manufacturers Navidea Biopharmaceuticals and an inhalable insulin therapy for diabetes from MannKind Corporation, while publicly short-selling the companies' stocks. Both companies' stock values immediately dropped following Shkreli's interventions, and the companies had difficulty launching the products as a result. The FDA subsequently approved both therapies.[5][.


I don't think times have changed that much. Sounds like a dirtbag that will do any thing for money much like the Magnus guy. Doesnt make me feel better having Gerald compared to him. Maybe if Gerald were making his shareholders rich he could get away with it like Shkreli apparently does. So far he has done the opposite.